...
首页> 外文期刊>Immunobiology: Zeitschrift fur Immunitatsforschung >Expression and clinical significance of Centrosomal protein 55 (CEP55) in human urinary bladder transitional cell carcinoma
【24h】

Expression and clinical significance of Centrosomal protein 55 (CEP55) in human urinary bladder transitional cell carcinoma

机译:中心体蛋白55(CEP55)在人膀胱移行细胞癌中的表达及其临床意义

获取原文
获取原文并翻译 | 示例
           

摘要

Bladder cancer (BC) is one among the most common and lethal urothelial malignancies worldwide. The expression of cancer-testis (CT) antigens in some tumours and restricted expression among normal tissues make CT antigens as attractive vaccine targets. In this context, we evaluated Centrosomal protein 55 kDa (CEP55), which is specifically expressed in normal human testis and various malignancies. Until the expression pattern of CEP55 in transitional cell carcinoma (TCC) of human urinary bladder and its clinical significance are not known. The aim of the present study is to evaluate mRNA/protein expression of CEP55 in TCCs of urinary bladder and correlate its expression with the clinicopathological characteristics of BC patients. In this study, the methods of quantitative real-time polymerase chain reaction (qRT-PCR) and immunohistochemistry (IHC) were used to investigate mRNA/protein expression of CEP55 in TCC. Independent Student's t test, ANOVA and Chi-square (chi(2)) were used to analyze the data statistically.
机译:膀胱癌(BC)是世界上最常见和致命的尿路上皮恶性肿瘤之一。睾丸癌(CT)抗原在某些肿瘤中的表达以及正常组织之间的限制性表达使CT抗原成为有吸引力的疫苗靶标。在这种情况下,我们评估了55 kDa的中心体蛋白(CEP55),该蛋白在正常人的睾丸和各种恶性肿瘤中特异性表达。直到CEP55在人膀胱移行细胞癌(TCC)中的表达模式及其临床意义才知道。本研究的目的是评估膀胱癌TCC中CEP55的mRNA /蛋白表达,并将其表达与BC患者的临床病理特征相关联。在这项研究中,定量实时聚合酶链反应(qRT-PCR)和免疫组织化学(IHC)的方法被用来研究TCP中CEP55的mRNA /蛋白质表达。使用独立学生t检验,方差分析和卡方(chi(2))进行统计分析。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号